COVID-Flu Vax on the Horizon; Counterfeit Diabetes Devices; Surviving Bird Flu Health news and commentary gathered by MedPage Today staff Jun 11, 2024
FDA Expands Use of RSV Vaccine to Include More Adults Arexvy now approved for people 50 years and older at increased risk of serious outcomes Jun 10, 2024
Missing Doc Found Dead; Trump's False Insulin Claim; CDC's Bird Flu Study Health news and commentary gathered by MedPage Today staff Jun 10, 2024
Bariatric Surgery Linked With Lower Mortality vs GLP-1 Drugs in Study, but ... Analysis of patients with obesity and diabetes only looked at first-generation GLP-1 agonists Jun 07, 2024
ENDO 2024 Roundup: Teen GLP-1 Coverage; Novel CAH Drug; Hot Flash Risks More research from the Endocrine Society's annual meeting Jun 05, 2024
Semaglutide May Boost Taste Sensitivity Other taste-related changes also potentially seen with the GLP-1 agent in proof-of-concept study Jun 02, 2024
High Price of Popular Diabetes Drugs Deprives Low-Income People of Effective Options "I'm having to jump through hoops to live," says one patient May 26, 2024
GLP-1 Agonists in Adolescents and Young Adults; Benefits of Cancer Drug Trials Also in TTHealthWatch: early diagnosis and treatment of COPD and asthma May 25, 2024 podcast
FDA Advisors Not Convinced Once-Weekly Insulin Is Safe in Type 1 Diabetes Risk of severe hypoglycemia was too much for panel members to overcome May 24, 2024
Ozempic Protects Kidneys, Boosts Survival in Diabetes Patients With CKD Phase III trial adds a fourth class shown to benefit this population May 24, 2024
Will FDA Advisors Look Past Hypoglycemia Risk With Once-Weekly Insulin? Hypoglycemia was only a concern in patients with type 1 diabetes May 22, 2024
Nutrition Experts Call on Congress to Advance 'Food Is Medicine' Movement Produce prescriptions, medically tailored meals improve quality of life, cut costs, they say May 22, 2024
GLP-1 Agonist Scripts Jumped 600% for Teens, Young Adults Since 2020 Females accounted for most of the prescription fills May 22, 2024
Yet Another Benefit for Metformin? Study suggests a surprising effect in rheumatologic disease risk May 17, 2024
Liver Disease, High Lipoprotein(a) Tied to Higher MI Risk in Diabetes Patients Sixfold increased risk of non-fatal MI among patients with highest levels of Lp(a) May 13, 2024
Which Patients With Diabetes and Ketoacidosis Face Higher Death Risk? Disparities in outcomes, healthcare use for type 2 versus type 1 disease May 12, 2024
Supported Exercise Intervention Helps Black Women With Obesity Shed Weight Pilot program cut HbA1c, boosted functional mobility, and fostered camaraderie May 11, 2024
Study Offers Clues on Asthma Control for Patients With Concurrent Diabetes Compared with metformin, some newer diabetes agents linked with more acute exacerbations May 10, 2024
FDA Warns on Insulin Pump Problem Mobile app glitch may cause t:slim X2 insulin pump battery to drain sooner than expected May 08, 2024
Some Patients Suffered Psychiatric Issues After Ozempic Initiation Two case reports detailed suicidal ideation, mania in weeks following semaglutide initiation May 05, 2024
Medicare Drug Price Negotiation; Diagnostic Errors Also in TTHealthWatch: neomycin for preventing respiratory viral infections May 04, 2024 podcast
'Evil Personified': Nurse Gets Life Sentence for Murdering Patients With Insulin 17 patients under the care of Heather Pressdee died following excessive doses May 03, 2024
FTC Challenges 'Bogus' Patents on Ozempic and Other Drugs Patents block competition and inflate prescription drug cost, says FTC chair May 01, 2024
What Do Weight-Loss Drugs Mean for Diet Industry Built on Eating Less and Exercise? Gym and diet food companies look to muscle in Apr 25, 2024
Ozempic Hiatus Before Surgery: Is a Weeklong Pause Really Needed? Incidence of respiratory complications similar to other antidiabetic agents, claims data suggest Apr 22, 2024
Time-Restricted Eating Tied to Modest Weight Loss Benefits appeared to come mainly from reduced caloric intake Apr 19, 2024
High Lipoprotein(a) Levels' Hit on Heart Health Doesn't Discriminate Atherogenic particle appeared to be a risk factor regardless of age, sex, race, diabetes status Apr 15, 2024
No Link Between GLP-1 Drugs and Suicide, Says European Regulator EMA announcement comes a few months after FDA's preliminary evaluation Apr 12, 2024
Study Assuages Thyroid Cancer Fears With GLP-1 Receptor Agonists Study findings support conclusions of the European Medicines Agency's recent investigation Apr 10, 2024
Chelation Flops for Cardio Health After Heart Attack TACT2 trial fails to confirm benefits in subgroup that gained the most in initial trial Apr 08, 2024
Wegovy Helps HFpEF Patients With Diabetes Mellitus Weight and symptoms improved in STEP-HFpEF DM trial Apr 07, 2024
Specialty Care Access Not Equal Among Teens With Diabetes Claims for specialists significantly lower for youth with type 2 versus type 1 diabetes Apr 05, 2024
Primary Care Strategy Fails to Reduce Kidney-Dysfunction Triad Hospitalizations Secondary outcomes also showed no significant differences Apr 03, 2024
Diabetes Drug Shows Benefit in Parkinson's Disease Phase II study of GLP-1 drug lixisenatide meets primary endpoint Apr 03, 2024
Weight-Loss Drug Zepbound Faces Supply Issues Following weight-loss indication, patients struggle to obtain tirzepatide Apr 02, 2024
When Medicalization Goes Too Far The boundaries between health and disease often get a little blurry Mar 31, 2024
Here's What OTC Continuous Glucose Monitors Can Do for Our Patients FDA's approval may be a step toward greater access Mar 30, 2024
Out-of-Pocket Insulin Caps Boost Savings -- But Not Insulin Use Proposed national $35 insulin cap would help some patients, researchers say Mar 25, 2024
Is SGLT2 Inhibitor-Associated Ketoacidosis Treated With Enough Insulin? Study suggests these patients receive significantly lower doses vs those with T1D ketoacidosis Mar 18, 2024
Slowing of Peripheral Artery Disease: Another Liraglutide Benefit? GLP-1 receptor agonist significantly slowed progression over 6 months Mar 13, 2024
